title: The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Singer
authors.forename: Margaret C
authors.initials: MC
authors.lastname: Fang
authors.forename: Alan S
authors.initials: AS
authors.lastname: Go
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000097:blood* / Q000150:complications*; D001777:Blood Coagulation; D002545:Brain Ischemia / Q000150:complications / Q000209:etiology; D006801:Humans; D019934:International Normalized Ratio; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013923:Thromboembolism / Q000150:complications / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage
chemical_list: D000925:Anticoagulants; D014859:Warfarin